"Target Name","ChEMBL-ID","Indication","Probability","Model accuracy"
"Cathepsin D","T67102","Hypertension [ICD-11: BA00-BA04]","95.77%","98.95%"
"Cathepsin D","T67102","Multiple sclerosis [ICD-11: 8A40]","95.77%","98.95%"
"HERG","T20251","Angina pectoris [ICD-11: BA40]","91.78%","89.76%"
"HERG","T20251","Cardiac arrhythmias [ICD-11: BC9Z]","91.78%","89.76%"
"HERG","T20251","Cardiac failure [ICD-11: BD10-BD13]","91.78%","89.76%"
"HERG","T20251","Heart arrhythmia [ICD-11: BC65]","91.78%","89.76%"
"HERG","T20251","Malaria [ICD-11: 1F40-1F45]","91.78%","89.76%"
"HERG","T20251","Multiple sclerosis [ICD-11: 8A40]","91.78%","89.76%"
"HERG","T20251","Ovarian cancer [ICD-11: 2C73]","91.78%","89.76%"
"HERG","T20251","Pain [ICD-11: MG30-MG3Z]","91.78%","89.76%"
"HERG","T20251","Sleep-wake disorder [ICD-11: 7A00-7B2Z]","91.78%","89.76%"
"Muscarinic acetylcholine receptor M5","T79961","Acquired nystagmus [ICD-11: 9C84]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Allergic rhinitis [ICD-11: CA08.0]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Alzheimer disease [ICD-11: 8A20]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Amnesia [ICD-11: MB21.1]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Asthma [ICD-11: CA23]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Brain disease [ICD-11: 8C70-8E61]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Central and peripheral nervous disease [ICD-11: 8A04-8E7Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Chronic obstructive pulmonary disease [ICD-11: CA22]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Cognitive impairment [ICD-11: 6D71]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Colitis [ICD-11: 1A40.Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Cough [ICD-11: MD12]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Depression [ICD-11: 6A70-6A7Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Dysmenorrhea [ICD-11: GA34.3]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Dysuria [ICD-11: MF50.7]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Examination of eyes or vision [ICD-11: QA00.6]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Gastric motility disorder [ICD-11: DA21]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Gastritis [ICD-11: DA42]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Gastrointestinal disease [ICD-11: DE2Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Glaucoma/ocular hypertension [ICD-11: 9C61]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Hypertension [ICD-11: BA00-BA04]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Irritable bowel syndrome [ICD-11: DD91.0]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Myasthenia gravis [ICD-11: 8C6Y]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Neurological disorder [ICD-11: 6B60]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Nocturia [ICD-11: MF55]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Organophosphate poisoning [ICD-11: NE6Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Overactive bladder [ICD-11: GC50.0]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Pancreatitis [ICD-11: DC31-DC34]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Parkinson disease [ICD-11: 8A00.0]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Peptic ulcer [ICD-11: DA61]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Psychomotor agitation [ICD-11: MB23.M]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Schizophrenia [ICD-11: 6A20]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Spasm [ICD-11: MB47.3]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Stomach ulcer [ICD-11: DA60.Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Suprapubic pain [ICD-11: MG30-MG3Z]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Urgency [ICD-11: N.A.]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Urinary incontinence [ICD-11: MF50.2]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Urinary retention [ICD-11: MF50.3]","90.71%","94.62%"
"Muscarinic acetylcholine receptor M5","T79961","Uveitis [ICD-11: 9A96.Z]","90.71%","94.62%"
"Glutathione S-transferase Pi","T21669","Myelodysplastic syndrome [ICD-11: 2A37]","85.33%","93.81%"
"Glutathione S-transferase Pi","T21669","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","85.33%","93.81%"
"Pregnane X receptor","T82702","Arteriosclerosis [ICD-11: BD40]","82.79%","94.73%"
"Muscarinic acetylcholine receptor M4","T20709","Asthma [ICD-11: CA23]","80.99%","94.08%"
"Muscarinic acetylcholine receptor M4","T20709","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","80.99%","94.08%"
"Muscarinic acetylcholine receptor M4","T20709","bronchial hyperreactivity [ICD-11: CB40]","80.99%","94.08%"
"Muscarinic acetylcholine receptor M4","T20709","Glaucoma/ocular hypertension [ICD-11: 9C61]","80.99%","94.08%"
"Muscarinic acetylcholine receptor M4","T20709","Mydriasis [ICD-11: LA11.62]","80.99%","94.08%"
"Muscarinic acetylcholine receptor M4","T20709","Nausea [ICD-11: MD90]","80.99%","94.08%"
"Histone deacetylase 4","T63816","Advanced stage follicular lymphoma [ICD-11: 2A80]","80.12%","92.97%"
"Histone deacetylase 4","T63816","Huntington disease [ICD-11: 8A01.10]","80.12%","92.97%"
"Histone deacetylase 4","T63816","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","80.12%","92.97%"
"Protein Mdm4","T36741","Acute myeloid leukaemia [ICD-11: 2A60]","75.24%","90.2%"
"Protein Mdm4","T36741","Haematological malignancy [ICD-11: 2B33.Y]","75.24%","90.2%"
"Protein Mdm4","T36741","Myelodysplastic syndrome [ICD-11: 2A37]","75.24%","90.2%"
"Protein Mdm4","T36741","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","75.24%","90.2%"
"DNA-(apurinic or apyrimidinic site) lyase","T13348","Glioma [ICD-11: 2A00.0]","74.38%","91.11%"
"DNA-(apurinic or apyrimidinic site) lyase","T13348","Melanoma [ICD-11: 2C30]","74.38%","91.11%"
"DNA-(apurinic or apyrimidinic site) lyase","T13348","Ocular cancer [ICD-11: 2D00-2D07]","74.38%","91.11%"
"DNA-(apurinic or apyrimidinic site) lyase","T13348","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","74.38%","91.11%"
"Serotonin 7 (5-HT7) receptor","T79062","Alzheimer disease [ICD-11: 8A20]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Bipolar disorder [ICD-11: 6A60]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Major depressive disorder [ICD-11: 6A70.3]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Parkinson disease [ICD-11: 8A00.0]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Psychiatric disorder [ICD-11: 6E8Z]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Schizophrenia [ICD-11: 6A20]","73.71%","90.71%"
"Serotonin 7 (5-HT7) receptor","T79062","Sleep-wake disorder [ICD-11: 7A00-7B2Z]","73.71%","90.71%"
"Aminopeptidase N","T67272","Psoriasis vulgaris [ICD-11: EA90]","73.39%","93.31%"
"Tyrosine-protein kinase ITK/TSK","T91761","Allergy [ICD-11: 4A80-4A85]","72.89%","95%"
"Tyrosine-protein kinase ITK/TSK","T91761","Inflammation [ICD-11: 1A00-CA43.1]","72.89%","95%"
"Tyrosine-protein kinase ITK/TSK","T91761","Plaque psoriasis [ICD-11: EA90.0]","72.89%","95%"
"ADAM10","T31902","Breast cancer [ICD-11: 2C60-2C65]","70.83%","97.5%"
"ADAM10","T31902","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","70.83%","97.5%"
"Formyl peptide receptor 1","T87831","Inflammation [ICD-11: 1A00-CA43.1]","67.83%","93.56%"
"Formyl peptide receptor 1","T87831","Peptic ulcer [ICD-11: DA61]","67.83%","93.56%"
"Tissue factor pathway inhibitor","T78890","Factor IX deficiency [ICD-11: 3B11]","65.72%","97.33%"
"Tissue factor pathway inhibitor","T78890","Sepsis [ICD-11: 1G40-1G41]","65.72%","97.33%"
"Choline kinase alpha","T55709","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","65.39%","78%"
"Muscarinic acetylcholine receptor M1","T28893","Abdominal stomach pain [ICD-11: DD91.4]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Alzheimer disease [ICD-11: 8A20]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Anaesthesia [ICD-11: 9A78.6]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Chronic obstructive pulmonary disease [ICD-11: CA22]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Cognitive impairment [ICD-11: 6D71]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Dementia [ICD-11: 6D80-6D86]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Dyslipidemia [ICD-11: 5C80-5C81]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Dystonia [ICD-11: 8A02]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Excessive sweating [ICD-11: EE00.Z]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Glaucoma/ocular hypertension [ICD-11: 9C61]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Infantile spasm [ICD-11: 8A62.0]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Inflammatory bowel disease [ICD-11: DD72]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Irritable bowel syndrome [ICD-11: DD91.0]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Neurological disorder [ICD-11: 6B60]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Neuropathic pain [ICD-11: 8E43.0]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Obesity [ICD-11: 5B81]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Overactive bladder [ICD-11: GC50.0]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Parkinson disease [ICD-11: 8A00.0]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Peptic ulcer [ICD-11: DA61]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Peripheral neuropathy [ICD-11: 8C0Z]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Rett syndrome [ICD-11: LD90.4]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Schizoaffective disorder [ICD-11: 6A21]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Schizophrenia [ICD-11: 6A20]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Seborrhea [ICD-11: ED91.2]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Stomach ulcer [ICD-11: DA60.Z]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Urinary incontinence [ICD-11: MF50.2]","64.17%","94.23%"
"Muscarinic acetylcholine receptor M1","T28893","Visceral spasms [ICD-11: MD81.4]","64.17%","94.23%"
"Histone deacetylase 8","T28887","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","63.99%","93.99%"
"Adenosine A1 receptor","T92072","Acute and chronic heart failure [ICD-11: BD1Z]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Allergy [ICD-11: 4A80-4A85]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Atrial fibrillation [ICD-11: BC81.3]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Autoimmune diabetes [ICD-11: 5A10]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Cardiac arrhythmias [ICD-11: BC9Z]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Cardiac disease [ICD-11: BA00-BE2Z]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Cognitive impairment [ICD-11: 6D71]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Diabetic complication [ICD-11: 5A2Y]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Glaucoma/ocular hypertension [ICD-11: 9C61]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Heart failure [ICD-11: BD10-BD13]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Hyperlipidaemia [ICD-11: 5C80]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Hypertension [ICD-11: BA00-BA04]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Hypertriglyceridemia [ICD-11: 5C80.1]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Multiple sclerosis [ICD-11: 8A40]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Neuropathic pain [ICD-11: 8E43.0]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Orthostatic hypotension [ICD-11: BA21]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Parkinson disease [ICD-11: 8A00.0]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Renal failure [ICD-11: GB60-GB6Z]","63.46%","95.93%"
"Adenosine A1 receptor","T92072","Sepsis [ICD-11: 1G40-1G41]","63.46%","95.93%"
"Serotonin 2c (5-HT2c) receptor","T83813","Alcohol dependence [ICD-11: 6C40.2]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Alzheimer disease [ICD-11: 8A20]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Anxiety disorder [ICD-11: 6B00-6B0Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Depression [ICD-11: 6A70-6A7Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Diabetic complication [ICD-11: 5A2Y]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Drug abuse [ICD-11: 6C4G.1Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Dyskinesia [ICD-11: MB47.4]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Generalized anxiety disorder [ICD-11: 6B00]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Hyperprolactinaemia [ICD-11: 5A60.1]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Major depressive disorder [ICD-11: 6A70.3]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Metabolic disorder [ICD-11: 5C50-5D2Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Migraine [ICD-11: 8A80]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Mood disorder [ICD-11: 6A60-6E23]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Neurological disorder [ICD-11: 6B60]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Non-hodgkin lymphoma [ICD-11: 2B33.5]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Obesity [ICD-11: 5B81]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Pain [ICD-11: MG30-MG3Z]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Parkinson disease [ICD-11: 8A00.0]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Primary insomnia [ICD-11: 7A00]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Psychotic disorder [ICD-11: 6A20-6A25]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Schizophrenia [ICD-11: 6A20]","62.6%","89.62%"
"Serotonin 2c (5-HT2c) receptor","T83813","Sleep-wake disorder [ICD-11: 7A00-7B2Z]","62.6%","89.62%"
"G-protein coupled receptor 55","T87670","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","62.54%","78.15%"
"Beta-glucuronidase","T96413","Mucopolysaccharidosis [ICD-11: 5C56.3]","62.19%","77.68%"
"Beta-glucuronidase","T96413","Periodontal disease [ICD-11: DA0C]","62.19%","77.68%"
"Histone deacetylase 10","T94324","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","61.6%","90.08%"
"Maternal embryonic leucine zipper kinase","T96892","Acute lymphoblastic leukaemia [ICD-11: 2A85]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Acute lymphoblastic leukaemia [ICD-11: 2A85]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Acute myeloid leukaemia [ICD-11: 2A60]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Acute myeloid leukaemia [ICD-11: 2A60]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Breast cancer [ICD-11: 2C60-2C65]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Breast cancer [ICD-11: 2C60-2C65]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Chronic lymphocytic leukaemia [ICD-11: 2A82.0]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Chronic lymphocytic leukaemia [ICD-11: 2A82.0]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Myelodysplastic syndrome [ICD-11: 2A37]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Myelodysplastic syndrome [ICD-11: 2A37]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Myeloproliferative neoplasm [ICD-11: 2A20]","61.51%","81.58%"
"Maternal embryonic leucine zipper kinase","T96892","Myeloproliferative neoplasm [ICD-11: 2A20]","61.51%","81.58%"
"Multidrug resistance-associated protein 1","T11288","Gout [ICD-11: FA25]","58.68%","96.37%"
"Cyclin-dependent kinase 2","T70176","Acute lymphoblastic leukaemia [ICD-11: 2A85]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Anaplastic astrocytoma [ICD-11: 2A00.0]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Haematological malignancy [ICD-11: 2B33.Y]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Lymphoma [ICD-11: 2A80-2A86]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Nasopharyngeal carcinoma [ICD-11: 2B6B]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Non-small-cell lung cancer [ICD-11: 2C25.Y]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Obesity [ICD-11: 5B81]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Recurrent glioblastoma [ICD-11: 2A00.00]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Retinoblastoma [ICD-11: 2D02.2]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","56.71%","91.23%"
"Cyclin-dependent kinase 2","T70176","Thymic cancer [ICD-11: 2C27]","56.71%","91.23%"
"Muscarinic acetylcholine receptor M2","T46185","Addictive disorder [ICD-11: 6C50-6C5Z]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Alzheimer disease [ICD-11: 8A20]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Asthma [ICD-11: CA23]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","bronchial hyperreactivity [ICD-11: CB40]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Cardiovascular disease [ICD-11: BA00-BE2Z]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Glaucoma/ocular hypertension [ICD-11: 9C61]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Heart failure [ICD-11: BD10-BD13]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Nausea [ICD-11: MD90]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Overactive bladder [ICD-11: GC50.0]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Parkinson disease [ICD-11: 8A00.0]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Peptic ulcer [ICD-11: DA61]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Seborrhea [ICD-11: ED91.2]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Stabilize muscle contraction [ICD-11: FB3Z]","56.63%","94.97%"
"Muscarinic acetylcholine receptor M2","T46185","Urinary incontinence [ICD-11: MF50.2]","56.63%","94.97%"
"Neurokinin 2 receptor","T52790","Acute or chronic pain [ICD-11: MG30-MG31]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Anxiety disorder [ICD-11: 6B00-6B0Z]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Asthma [ICD-11: CA23]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Atopic dermatitis [ICD-11: EA80]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Chronic obstructive pulmonary disease [ICD-11: CA22]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Depression [ICD-11: 6A70-6A7Z]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Infantile colics [ICD-11: DD93.1]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Irritable bowel syndrome [ICD-11: DD91.0]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Pain [ICD-11: MG30-MG3Z]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Postoperative ileus [ICD-11: DA91-DB30]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Psoriasis vulgaris [ICD-11: EA90]","56.56%","98.89%"
"Neurokinin 2 receptor","T52790","Urinary incontinence [ICD-11: MF50.2]","56.56%","98.89%"
"Serotonin 2a (5-HT2a) receptor","T32060","Addictive disorder [ICD-11: 6C50-6C5Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Alcohol dependence [ICD-11: 6C40.2]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Alzheimer disease [ICD-11: 8A20]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Anxiety disorder [ICD-11: 6B00-6B0Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Attention deficit hyperactivity disorder [ICD-11: 6A05.Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Benign prostatic hyperplasia [ICD-11: GA90]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Bipolar disorder [ICD-11: 6A60]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Cardiovascular disease [ICD-11: BA00-BE2Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Central nervous system disease [ICD-11: 8A04-8D87]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Cerebrovascular ischaemia [ICD-11: 8B1Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Depression [ICD-11: 6A70-6A7Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Diabetic complication [ICD-11: 5A2Y]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Diabetic nephropathy [ICD-11: GB61.Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Erythropoietic porphyrias [ICD-11: 5C58.12]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Female sexual arousal dysfunction [ICD-11: HA01.1]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Fibromyalgia [ICD-11: MG30.01]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Glaucoma/ocular hypertension [ICD-11: 9C61]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Hemorrhoids [ICD-11: DB60]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Hyperprolactinaemia [ICD-11: 5A60.1]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Hypertension [ICD-11: BA00-BA04]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Idiopathic pulmonary fibrosis [ICD-11: CB03.4]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Insomnia [ICD-11: 7A00-7A0Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Lewy body dementia [ICD-11: 6D82]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Major depressive disorder [ICD-11: 6A70.3]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Migraine [ICD-11: 8A80]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Mood disorder [ICD-11: 6A60-6E23]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Pancreatic cancer [ICD-11: 2C10]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Pancreatitis [ICD-11: DC31-DC34]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Parkinson disease [ICD-11: 8A00.0]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Post-traumatic stress disorder [ICD-11: 6B40]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Primary insomnia [ICD-11: 7A00]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Psychiatric disorder [ICD-11: 6E8Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Psychotic disorder [ICD-11: 6A20-6A25]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Schizoaffective disorder [ICD-11: 6A21]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Schizophrenia [ICD-11: 6A20]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Sleep-wake disorder [ICD-11: 7A00-7B2Z]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Social phobia [ICD-11: 6B04]","55.06%","91.43%"
"Serotonin 2a (5-HT2a) receptor","T32060","Type-2 diabetes [ICD-11: 5A11]","55.06%","91.43%"
"Sodium channel protein type III alpha subunit","T76937","Angina pectoris [ICD-11: BA40]","54.09%","96.9%"
"Sodium channel protein type III alpha subunit","T76937","Neurological disorder [ICD-11: 6B60]","54.09%","96.9%"
"Sodium channel protein type III alpha subunit","T76937","Pain [ICD-11: MG30-MG3Z]","54.09%","96.9%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Alzheimer disease [ICD-11: 8A20]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Alzheimer disease [ICD-11: 8A20]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Aneurysm [ICD-11: BD51.Z]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Hypertensive emergency [ICD-11: BA03]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Hypotension [ICD-11: BA20-BA21]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Tobacco dependence [ICD-11: 6C4A.2]","53.77%","100%"
"Neuronal acetylcholine receptor; alpha4/beta4","T73724","Tobacco dependence [ICD-11: 6C4A.2]","53.77%","100%"
"Glycine transporter 1","T69685","Dementia [ICD-11: 6D80-6D86]","53.77%","95.45%"
"Glycine transporter 1","T69685","Psychotic disorder [ICD-11: 6A20-6A25]","53.77%","95.45%"
"Glycine transporter 1","T69685","Schizophrenia [ICD-11: 6A20]","53.77%","95.45%"
"Voltage-gated potassium channel subunit Kv1.5","T17569","Angina pectoris [ICD-11: BA40]","53.68%","94.03%"
"Voltage-gated potassium channel subunit Kv1.5","T17569","Arrhythmia [ICD-11: BC9Z]","53.68%","94.03%"
"Voltage-gated potassium channel subunit Kv1.5","T17569","Atrial fibrillation [ICD-11: BC81.3]","53.68%","94.03%"
"Voltage-gated potassium channel subunit Kv1.5","T17569","Obesity [ICD-11: 5B81]","53.68%","94.03%"
"Voltage-gated potassium channel subunit Kv1.5","T17569","Pain [ICD-11: MG30-MG3Z]","53.68%","94.03%"
"C5a anaphylatoxin chemotactic receptor","T15439","Atopic dermatitis [ICD-11: EA80]","53.61%","92.62%"
"C5a anaphylatoxin chemotactic receptor","T15439","Eosinophilic granulomatosis with polyangiitis [ICD-11: 4A44.A2]","53.61%","92.62%"
"C5a anaphylatoxin chemotactic receptor","T15439","Hereditary haemolytic anemia [ICD-11: 3A10.3]","53.61%","92.62%"
"C5a anaphylatoxin chemotactic receptor","T15439","Inflammation [ICD-11: 1A00-CA43.1]","53.61%","92.62%"
"C5a anaphylatoxin chemotactic receptor","T15439","Rheumatoid arthritis [ICD-11: FA20]","53.61%","92.62%"
"C5a anaphylatoxin chemotactic receptor","T15439","Vasculitis [ICD-11: 4A44]","53.61%","92.62%"
"DNA topoisomerase I","T09826","Acquired immune deficiency syndrome [ICD-11: 1C62.3]","53.32%","97%"
"DNA topoisomerase I","T09826","Acute lymphoblastic leukaemia [ICD-11: 2A85]","53.32%","97%"
"DNA topoisomerase I","T09826","Bacterial infection [ICD-11: 1A00-1C4Z]","53.32%","97%"
"DNA topoisomerase I","T09826","Bladder cancer [ICD-11: 2C94]","53.32%","97%"
"DNA topoisomerase I","T09826","Breast cancer [ICD-11: 2C60-2C65]","53.32%","97%"
"DNA topoisomerase I","T09826","Colorectal cancer [ICD-11: 2B91.Z]","53.32%","97%"
"DNA topoisomerase I","T09826","Esophageal cancer [ICD-11: 2B70]","53.32%","97%"
"DNA topoisomerase I","T09826","Gastric adenocarcinoma [ICD-11: 2B72]","53.32%","97%"
"DNA topoisomerase I","T09826","Glioblastoma multiforme [ICD-11: 2A00.0]","53.32%","97%"
"DNA topoisomerase I","T09826","Human immunodeficiency virus infection [ICD-11: 1C62]","53.32%","97%"
"DNA topoisomerase I","T09826","Lung cancer [ICD-11: 2C25.0]","53.32%","97%"
"DNA topoisomerase I","T09826","Lymphoma [ICD-11: 2A80-2A86]","53.32%","97%"
"DNA topoisomerase I","T09826","Metastatic colorectal cancer [ICD-11: 2B91]","53.32%","97%"
"DNA topoisomerase I","T09826","Myelodysplastic syndrome [ICD-11: 2A37]","53.32%","97%"
"DNA topoisomerase I","T09826","Ovarian cancer [ICD-11: 2C73]","53.32%","97%"
"DNA topoisomerase I","T09826","Renal cell carcinoma [ICD-11: 2C90]","53.32%","97%"
"DNA topoisomerase I","T09826","Small-cell lung cancer [ICD-11: 2C25.Y]","53.32%","97%"
"DNA topoisomerase I","T09826","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","53.32%","97%"
"Thyroid hormone receptor alpha","T79591","Congestive heart failure [ICD-11: BD10]","52.38%","99.15%"
"Thyroid hormone receptor alpha","T79591","High blood cholesterol level [ICD-11: 5C80.00]","52.38%","99.15%"
"Thyroid hormone receptor alpha","T79591","Hypothyroidism [ICD-11: 5A00]","52.38%","99.15%"
"Thyroid hormone receptor alpha","T79591","Wound healing [ICD-11: EL8Y]","52.38%","99.15%"
"PI3-kinase p110-delta subunit","T67849","Arthritis [ICD-11: FA20]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Breast cancer [ICD-11: 2C60-2C65]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Chronic lymphocytic leukaemia [ICD-11: 2A82.0]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Cutaneous T-cell lymphoma [ICD-11: 2B01]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Diffuse large B-cell lymphoma [ICD-11: 2A81]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Follicular lymphoma [ICD-11: 2A80]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Follicular lymphoma [ICD-11: 2A80]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Hematologic tumour [ICD-11: 2B33.Y]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Lymphoma [ICD-11: 2A80-2A86]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Mantle cell lymphoma [ICD-11: 2A85.5]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Marginal zone lymphoma [ICD-11: 2A85.0]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Myeloid leukaemia [ICD-11: 2B33.1]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Non-hodgkin lymphoma [ICD-11: 2B33.5]","51.98%","96.47%"
"PI3-kinase p110-delta subunit","T67849","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","51.98%","96.47%"
"Neprilysin","T05409","Acute decompensated heart failure [ICD-11: BD1Z]","51.94%","92.63%"
"Neprilysin","T05409","Acute lymphoblastic leukaemia [ICD-11: 2A85]","51.94%","92.63%"
"Neprilysin","T05409","Asthma [ICD-11: CA23]","51.94%","92.63%"
"Neprilysin","T05409","Brain injury [ICD-11: NA07.Z]","51.94%","92.63%"
"Neprilysin","T05409","Cardiovascular disease [ICD-11: BA00-BE2Z]","51.94%","92.63%"
"Neprilysin","T05409","Chronic pain [ICD-11: MG30]","51.94%","92.63%"
"Neprilysin","T05409","Diabetic nephropathy [ICD-11: GB61.Z]","51.94%","92.63%"
"Neprilysin","T05409","Female sexual arousal dysfunction [ICD-11: HA01.1]","51.94%","92.63%"
"Neprilysin","T05409","Heart disease [ICD-11: BA41-BA42]","51.94%","92.63%"
"Neprilysin","T05409","Heart failure [ICD-11: BD10-BD13]","51.94%","92.63%"
"Neprilysin","T05409","Huntington disease [ICD-11: 8A01.10]","51.94%","92.63%"
"Neprilysin","T05409","Hypertension [ICD-11: BA00-BA04]","51.94%","92.63%"
"Neprilysin","T05409","Hypotension [ICD-11: BA20-BA21]","51.94%","92.63%"
"Neprilysin","T05409","leukaemia [ICD-11: 2A60-2B33]","51.94%","92.63%"
"Neprilysin","T05409","Multiple sclerosis [ICD-11: 8A40]","51.94%","92.63%"
"Neprilysin","T05409","Non-small-cell lung cancer [ICD-11: 2C25.Y]","51.94%","92.63%"
"Neprilysin","T05409","Pain [ICD-11: MG30-MG3Z]","51.94%","92.63%"
"Neprilysin","T05409","Renal failure [ICD-11: GB60-GB6Z]","51.94%","92.63%"
"Toll-like receptor 8","T48703","Allergic rhinitis [ICD-11: CA08.0]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Allergy [ICD-11: 4A80-4A85]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Autoimmune diabetes [ICD-11: 5A10]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Diffuse large B-cell lymphoma [ICD-11: 2A81]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Herpes simplex virus infection [ICD-11: 1F00]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Melanoma [ICD-11: 2C30]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","51.92%","96.25%"
"Toll-like receptor 8","T48703","Systemic lupus erythematosus [ICD-11: 4A40.0]","51.92%","96.25%"
"Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","T16308","Nasopharyngeal carcinoma [ICD-11: 2B6B]","51.83%","91.71%"
"Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","T16308","Non-small-cell lung cancer [ICD-11: 2C25.Y]","51.83%","91.71%"
"Dihydrofolate reductase","T17345","Acute bacterial skin infection [ICD-11: 1C41]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Bacterial infection [ICD-11: 1A00-1C4Z]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Bladder cancer [ICD-11: 2C94]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Inflammatory bowel disease [ICD-11: DD72]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Pneumonia [ICD-11: CA40]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Pulmonary and extrapulmonary tuberculosis [ICD-11: 1B10.Z]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Rheumatoid arthritis [ICD-11: FA20]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","51.72%","89.92%"
"Dihydrofolate reductase","T17345","Urinary tract infection [ICD-11: GC08]","51.72%","89.92%"
"Trypsin I","T27602","Asthma [ICD-11: CA23]","51%","90%"
"Trypsin I","T27602","Atopic dermatitis [ICD-11: EA80]","51%","90%"
"Trypsin I","T27602","Bacillus anthracis infection [ICD-11: 1G40]","51%","90%"
"Trypsin I","T27602","Coagulation defect [ICD-11: 3B10.0]","51%","90%"
"Trypsin I","T27602","Hypotension [ICD-11: BA20-BA21]","51%","90%"
"Trypsin I","T27602","Multiple myeloma [ICD-11: 2A83]","51%","90%"
"Trypsin I","T27602","Non-hodgkin lymphoma [ICD-11: 2B33.5]","51%","90%"
"Trypsin I","T27602","Premature labour [ICD-11: JB00]","51%","90%"
"Trypsin I","T27602","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","51%","90%"
"Cysteinyl leukotriene receptor 2","T74238","Asthma [ICD-11: CA23]","50.8%","98%"
"Tyrosine-protein kinase FYN","T17980","Chronic myelogenous leukaemia [ICD-11: 2A20.0]","50.06%","81.29%"
"Tyrosine-protein kinase FYN","T17980","Multiple myeloma [ICD-11: 2A83]","50.06%","81.29%"
"Tyrosine-protein kinase FYN","T17980","Solid tumour/cancer [ICD-11: 2A00-2F9Z]","50.06%","81.29%"